Tosoh Bioscience expands its GigaCap family of ion exchange resins by new small particle size versions that are suited for high resolution intermediate and polishing purification steps.
The renowned TOYOPEARL GigaCap ion exchange resins offer high binding capacities and excellent recoveries at high flow rates. They are ideally suited for high throughput purification of monoclonal antibodies and other biomolecules. Recently TOYOPEARL GigaCap DEAE was introduced to expand the choice of available functionalities by a weak anion exchange resins. Customer demands for smaller particle size versions of the existing resins initiated the development of TOYOPEARL GigaCap S-650S and Q-650S, which are now being launched.
TOYOPEARL GigaCap Q-650S is a strong anion exchange resin that combines high resolution with high binding capacity for oligonucleotide separation. TOYOPEARL GigaCap S-650S is a strong cation exchange resin and provides high resolution for better separation of process impurities and aggregates.
Tosoh Bioscience
Zettachring 6, 70567 Stuttgart, Germany
info.tbg@tosoh.comwww.tosohbioscience.de
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT: OVERCOMING CHALLENGES IN ORAL DELIVERY
February 14th 2025Obesity is a significant global health challenge that requires lifestyle changes and effective pharmacological treatments to overcome. Human glucagon-like peptide 1 (GLP-1) analogs, also called incretin mimetics, have emerged as a promising obesity treatment option. Additionally, oral GLP-1 formulations represent a groundbreaking advance in obesity treatment, offering greater patient comfort and adherence to expand the therapeutic market.